JOSEPH GIANNOLA

Allopathic & Osteopathic Physicians|Family Medicine LIVONIA, MI NPI 1992772271

General Payments — all program years on this page

$774.63

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 51
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $322.74 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $322.7419

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $170.8013
2019 $150.6212
2023 $130.477
2024 $322.7419

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082143667 Dynavax Technologies Corporation $16.91 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082145467 Dynavax Technologies Corporation $16.91 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096592184 Novo Nordisk Inc $17.96 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104223337 AstraZeneca Pharmaceuticals LP $15.28 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104492446 AstraZeneca Pharmaceuticals LP $15.40 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104570968 AstraZeneca Pharmaceuticals LP $15.04 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105295896 AstraZeneca Pharmaceuticals LP $13.36 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105504560 AstraZeneca Pharmaceuticals LP $13.53 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105811051 AstraZeneca Pharmaceuticals LP $17.66 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114673458 Exact Sciences Corporation $14.72 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116418338 GlaxoSmithKline, LLC. $13.11 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117260421 Amgen Inc. $16.92 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118897652 Otsuka America Pharmaceutical, Inc. $26.23 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125379848 Abbott Laboratories $23.79 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125379850 Abbott Laboratories $18.45 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131871139 PFIZER INC. $16.70 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150123295 SHIELD THERAPEUTICS INC $14.31 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150127635 SHIELD THERAPEUTICS INC $14.67 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153453889 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.79 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.